BRAF and melanoma: A recent study using A2058 cells, expressing the BRAF oncogenic mutation (BRAFV600E), showed that fucoxanthin from the haptophyte Tisochrysis lutea is able to restore melanoma cells sensitivity to BRAFi (vemurafenib) and alkylating (dacarbazine) agents.